Literature DB >> 15021050

New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease.

Sanjay Sethi1.   

Abstract

PURPOSE OF REVIEW: Acute exacerbations of chronic obstructive pulmonary disease were a poorly defined and understood entity. The application of better study designs and new research methodologies has shed considerable light on the pathogenesis of this common clinical syndrome. RECENT
FINDINGS: Inflammation is an important component of the pathogenesis of chronic obstructive pulmonary disease, and exacerbations probably represent acute increases in airway inflammation brought about by one or more etiological agents. Environmental particulate and gaseous pollutants have been linked in epidemiological studies with increased respiratory symptoms and mortality in chronic obstructive pulmonary disease. Bacterial, viral and atypical pathogens, either alone or in concert, induce the majority of acute exacerbations.
SUMMARY: A bacterial cause of a substantial proportion of exacerbations is now firmly established by the results of bronchoscopy, molecular epidemiology, immunology and airway inflammation studies. Future research should focus on pathogenic mechanisms and host defence against the microbial pathogens associated with acute exacerbations of chronic obstructive pulmonary disease, in order to develop better treatment and prevention strategies.

Entities:  

Mesh:

Year:  2004        PMID: 15021050     DOI: 10.1097/00001432-200404000-00008

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  15 in total

1.  Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination.

Authors:  Meng Chen; Yuki Hisatomi; Akitsugu Furumoto; Kenji Kawakami; Hironori Masaki; Tsuyoshi Nagatake; Yoshiko Sueyasu; Tomoaki Iwanaga; Hisamichi Aizawa; Kazunori Oishi
Journal:  Clin Vaccine Immunol       Date:  2006-12-13

Review 2.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

3.  CeO2 nanoparticles attenuate airway mucus secretion induced by TiO2 nanoparticles.

Authors:  Shih-Ming Tsai; Edith Duran-Robles; Tyler Goshia; Maria Mesina; Carlos Garcia; Julia Young; Angelo Sibal; Meng-Hsuen Chiu; Wei-Chun Chin
Journal:  Sci Total Environ       Date:  2018-03-16       Impact factor: 7.963

4.  The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance.

Authors:  Ahmed S Attia; Eric R Lafontaine; Jo L Latimer; Christoph Aebi; George A Syrogiannopoulos; Eric J Hansen
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.

Authors:  Ann R Falsey; Maria A Formica; Patricia A Hennessey; Mary M Criddle; Wayne M Sullender; Edward E Walsh
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

6.  Hochu-ekki-to inhibits rhinovirus infection in human tracheal epithelial cells.

Authors:  M Yamaya; T Sasaki; H Yasuda; D Inoue; T Suzuki; M Asada; M Yoshida; T Seki; K Iwasaki; H Nishimura; K Nakayama
Journal:  Br J Pharmacol       Date:  2007-02-19       Impact factor: 8.739

7.  Functionalized positive nanoparticles reduce mucin swelling and dispersion.

Authors:  Eric Y T Chen; Yung-Chen Wang; Chi-Shuo Chen; Wei-Chun Chin
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

8.  Mucin secretion induced by titanium dioxide nanoparticles.

Authors:  Eric Y T Chen; Maria Garnica; Yung-Chen Wang; Chi-Shuo Chen; Wei-Chun Chin
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

Review 9.  Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.

Authors:  Maria Tsoumakidou; Nikolaos M Siafakas
Journal:  Respir Res       Date:  2006-05-22

Review 10.  Optimizing antibiotic selection in treating COPD exacerbations.

Authors:  Attiya Siddiqi; Sanjay Sethi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.